Skip to main content
Published locations for T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab
User login
Username
Password
Reset your password
/content/t-cell-response-after-third-sars-cov-2-vaccination-patients-ms-ocrelizumab
/neurology/msresourcecenter/article/254734/multiple-sclerosis/t-cell-response-after-third-sars-cov-2